Gliomatosis cerebri: Difference between revisions
No edit summary |
(Mahshid) |
||
(2 intermediate revisions by one other user not shown) | |||
Line 49: | Line 49: | ||
[[Category:Neurosurgery]] | [[Category:Neurosurgery]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Neurology]] | |||
[[Category:Neurosurgery]] |
Latest revision as of 01:45, 27 November 2017
Gliomatosis cerebri Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Gliomatosis cerebri On the Web |
American Roentgen Ray Society Images of Gliomatosis cerebri |
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Synonyms and keywords: Infiltrative diffuse astrocytosis; astrocytosis cerebri; glioblastosis cerebri; GC; diffuse gliomatosis; glioblastosis; central diffuse schwannosis; diffuse glioma of the brain; diffuse glioma of brain; gliomatous hypertrophy; blastomatous type of diffuse sclerosis; gliomatosis diffusa; glioblastoma multiforme; astrocytoma; brain tumor
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gliomatosis cerebri from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies